SIMPLIFIED RULES TO IDENTIFY BIO-NAÏVE PATIENTS WITH CROHN’S DISEASE WITH HIGHER LIKELIHOOD OF CLINICAL REMISSION WHEN INITIATING VEDOLIZUMAB VERSUS ANTI-TNF THERAPIES: ANALYSIS OF EVOLVE STUDY DATA

Gerassimos J. Mantzaris  1     Andres Yarur  2     Annie Guerin  3     Pravin Kamble  4     Michelle Luo  5     Song Wang  6     Ha Nguyen  3     Emma Billmyer  7     Brian Bressler     Shashi Adsul    
1 Evangelismos Hospital,Athens,Greece
2 Medical College of Wisconsin,Milwaukee,United States
3 Analysis Group,Boston,United States
4 Takeda Pharmaceuticals Inc.,Cambridge,United States
5 Takeda,Cambridge,United States
6 Takeda Pharmaceuticals International Co.,Cambridge,United States
7 Analysis Group,Bos

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing